These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22545245)

  • 1. Using modeling to help understand vaginal microbicide functionality and create better products.
    Katz DF; Gao Y; Kang M
    Drug Deliv Transl Res; 2011 Jun; 1(3):256-76. PubMed ID: 22545245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupled gel spreading and diffusive transport models describing microbicidal drug delivery.
    Funke C; MacMillan K; Ham A; Szeri AJ; Katz DF
    Chem Eng Sci; 2016 Oct; 152():12-20. PubMed ID: 28042165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the vaginal delivery route for antiretrovirals in HIV prevention.
    Ferguson LM; Rohan LC
    Ther Deliv; 2011 Dec; 2(12):1535-50. PubMed ID: 22468220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide.
    Tasoglu S; Katz DF; Szeri AJ
    J Nonnewton Fluid Mech; 2012 Nov; 187-188():36-42. PubMed ID: 23425996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic modeling of a gel-delivered dapivirine microbicide in humans.
    Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Sci; 2016 Oct; 93():410-8. PubMed ID: 27559026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
    Kieweg SL; Katz DF
    J Biomech Eng; 2006 Aug; 128(4):540-53. PubMed ID: 16813445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1.
    Buckheit KW; Buckheit RW
    Mol Biol Int; 2012; 2012():781305. PubMed ID: 22848826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV.
    Buckheit KW; Furlan-Freguia C; Ham AS; Buckheit RW
    Curr Top Med Chem; 2016; 16(10):1118-34. PubMed ID: 26324047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography.
    Chuchuen O; Maher JR; Henderson MH; Desoto M; Rohan LC; Wax A; Katz DF
    PLoS One; 2017; 12(9):e0185633. PubMed ID: 28961280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
    Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.
    McGowan I; Taylor DJ
    Sex Transm Dis; 2010 Jun; 37(6):361-4. PubMed ID: 20514687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.
    Lai BE; Geonnotti AR; Desoto MG; Montefiori DC; Katz DF
    Antiviral Res; 2010 Nov; 88(2):143-51. PubMed ID: 20709109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
    Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
    Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice.
    Neff CP; Kurisu T; Ndolo T; Fox K; Akkina R
    PLoS One; 2011; 6(6):e20209. PubMed ID: 21673796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory.
    Geonnotti AR; Katz DF
    Biophys J; 2006 Sep; 91(6):2121-30. PubMed ID: 16815899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity Analysis of a Pharmacokinetic Model of Vaginal Anti-HIV Microbicide Drug Delivery.
    Jarrett AM; Gao Y; Hussaini MY; Cogan NG; Katz DF
    J Pharm Sci; 2016 May; 105(5):1772-1778. PubMed ID: 27012224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of virus transmission inhibition by dual-acting pyrimidinedione microbicides using the microbicide transmission and sterilization assay.
    Watson KM; Buckheit CE; Buckheit RW
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2787-96. PubMed ID: 18559653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
    Adams JL; Kashuba AD
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):451-62. PubMed ID: 22306523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.